Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on …

S Greppmair, A Brinkmann, A Roehr, O Frey… - Intensive Care …, 2023 - Springer
Purpose Inadequate piperacillin (PIP) exposure in intensive care unit (ICU) patients
threatens therapeutic success. Model-informed precision dosing (MIPD) might be promising …

Sepsis Stewardship: the puzzle of antibiotic therapy in the context of individualization of decision making

F Ramasco, R Méndez, A Suarez de la Rica… - Journal of Personalized …, 2024 - mdpi.com
The main recent change observed in the field of critical patient infection has been universal
awareness of the need to make better use of antimicrobials, especially for the most serious …

Population pharmacokinetic model of cefepime for critically ill adults: a comparative assessment of eGFR equations

EF Barreto, J Chang, AD Rule, KC Mara… - Antimicrobial Agents …, 2023 - Am Soc Microbiol
Cefepime exhibits highly variable pharmacokinetics in critically ill patients. The purpose of
this study was to develop and qualify a population pharmacokinetic model for use in the …

Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis

MG Chai, Q Tu, MO Cotta, MJ Bauer, R Balch… - Intensive Care …, 2024 - Springer
Purpose Early recognition and effective treatment of sepsis improves outcomes in critically ill
patients. However, antibiotic exposures are frequently suboptimal in the intensive care unit …

Exploring the Impact of Model-Informed Precision Dosing on Procalcitonin Concentrations in Critically Ill Patients: A Secondary Analysis of the DOLPHIN Trial

S Dräger, TMJ Ewoldt, A Abdulla, WJR Rietdijk… - Pharmaceutics, 2024 - mdpi.com
Model-informed precision dosing (MIPD) might be used to optimize antibiotic treatment.
Procalcitonin (PCT) is a biomarker for severity of infection and response to antibiotic …

Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study

P Kovacevic, D Milakovic, T Kovacevic… - Naunyn-Schmiedeberg's …, 2024 - Springer
Patients treated with ECMO are at great risk of nosocomial infections, and around 10% of
isolates are gram-positive pathogens. Linezolid (LZD) is effective in the treatment of these …

Individualised dosing of antibiotics in ICU patients: timing, target and model selection matter. Author's reply

TMJ Ewoldt, A Abdulla, AE Muller, H Endeman… - Intensive Care …, 2023 - Springer
We would like to thank Liebchen et al.[1] for their comments on our article.[2] Furthermore,
we would like to thank Cotta and colleagues, who wrote a relevant editorial regarding the …

[引用][C] Personalising antimicrobial therapy in critically ill patients using Bayesian dosing software

M Chai - 2024 - espace.library.uq.edu.au
Infections in critically ill patients are associated with significant morbidity and mortality
whereby prompt administration of antimicrobials is crucial to help optimise treatment …